Discover how Oria Bioscience was honored as an i-Lab 2024 laureate for its innovative Lyflow project, using microfluidics to revolutionize biotechnology. A major milestone supported by France 2030.
Oria Bioscience is proud to be recognized as a laureate of the prestigious i-Lab 2024 competition in the Biotechnology category. This competition, supported by the French Government, ADEME, and Bpifrance under the France 2030 initiative, celebrates the most innovative projects.
The i-Lab competition is a national contest aimed at identifying and supporting the most promising innovative projects in France. It serves as a catalyst for technological advancement and economic growth by providing financial support and visibility to startups and research projects. The stakes are high, as being recognized by i-Lab not only brings financial aid but also enhances credibility and opens doors to further opportunities in the innovation ecosystem.
Before achieving the i-Lab laureate status in 2024, Oria Bioscience's CEO, Alexandre Santinho, was an i-PhD laureate. This earlier recognition highlights the continuous journey of innovation and excellence that Oria Bioscience has embarked upon, showcasing the leadership and vision driving the company forward.
Our project, Lyflow, stands out with its unique approach to perfect and standardize our Lysosome using microfluidics technology. The objective is also to improve production capabilities. This recognition marks a significant milestone in our journey, reinforcing our commitment to innovation and scientific excellence.
We join 177 other innovative projects, all supported by the State, in this exciting venture. Congratulations to all the laureates! This achievement underscores the importance of collaboration and support from key institutions like ADEME and Bpifrance, which play a crucial role in fostering innovation and sustainability in France.
